Zymedi

Zymeworks

The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.

aTyr Pharma

The company develops protein-based immunomodulatory medicines for patients suffering from inflammatory lung diseases, such as pulmonary sarcoidosis, and various types of cancer.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Triveni Bio

This biotechnology company develops antibody-based therapies for patients with immunological and inflammatory disorders using a genetics-informed precision medicine approach.

Cellemedy

The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

LTZ Therapeutics

This biopharma company develops myeloid engager immunotherapies for patients with cancer and autoimmune diseases.